Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03684460 · ClinicalTrials.gov registry record · NA

Daytime Bright Light, Circadian Abnormalities, and Delirium in Medical ICU Patients

A NA study of Circadian Rhythm Disorders, sponsored by Yale University.

Completed
Registry status
NA
Development phase
68
Enrollment target
1
Study location

NCT03684460 is a NA study of Circadian Rhythm Disorders that has completed, run by Yale University. The registered enrollment target is 68 participants, below the 109-participant average among 7 other Circadian Rhythm Disorders trials with a reported enrollment target (38% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03684460, a NA study of Circadian Rhythm Disorders, has completed, sponsored by Yale University.

COMPLETED
Registry status
NA
Development phase
68 participants
Enrollment target
1
Study location

Study Summary

To determine if daytime bright light will promote circadian alignment and shorten or prevent delirium.

Conditions Studied

Interventions

  • DEVICE Daytime Bright Light
  • DEVICE Usual Light

Study Locations (1)

Connecticut

  • Yale New Haven Hospital, York Street Campus - New Haven

Trial Details

FieldValue
Enrollment Target 68 participants
Start Date 2019-07-08
Est. Completion 2024-03-28
Phase NA

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT03684460

The ClinicalTrials.gov registry entry for NCT03684460 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 109-participant average among 7 other Circadian Rhythm Disorders trials with a reported enrollment target (38% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Circadian Rhythm Disorders appearing as the primary indexed condition, and to 2 interventions - of which Daytime Bright Light is the first listed.

NCT03684460 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT03684460 about?

NCT03684460 is a clinical study titled "Daytime Bright Light, Circadian Abnormalities, and Delirium in Medical ICU Patients". To determine if daytime bright light will promote circadian alignment and shorten or prevent delirium.

What is the current status of trial NCT03684460?

This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2019-07-08. Estimated completion is 2024-03-28.

What conditions does trial NCT03684460 study?

This clinical trial studies the following conditions: Circadian Rhythm Disorders.

What interventions are being tested in trial NCT03684460?

The interventions under investigation include: Daytime Bright Light (DEVICE), Usual Light (DEVICE).

Who is sponsoring clinical trial NCT03684460?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03684460 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Circadian Rhythm Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.